• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从玫瑰链霉菌79089中分离得到的高选择性新型内皮素转化酶抑制剂WS79089B的生物学和药理学特性

Biological and pharmacological properties of highly selective new endothelin converting enzyme inhibitor WS79089B isolated from Streptosporangium roseum No. 79089.

作者信息

Tsurumi Y, Fujie K, Nishikawa M, Kiyoto S, Okuhara M

机构信息

Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Ibaraki, Japan.

出版信息

J Antibiot (Tokyo). 1995 Feb;48(2):169-74. doi: 10.7164/antibiotics.48.169.

DOI:10.7164/antibiotics.48.169
PMID:7706129
Abstract

WS79089B a highly specific endothelin converting enzyme (ECE) inhibitor has been isolated from the fermentation broth of Streptosporangium roseum No. 79089. WS79089B showed highly selective ECE inhibition activity with IC50 value of 0.14 microM and behaved as a competitive inhibitor of ECE, with Ki values of 8.9 x 10(-8) M. The sodium salt of WS79089B (FR901533) inhibited big endothelin-1 (big ET-1) induced pressor effect in a dose dependent manner when administered to male Sprague-Dawley rats intravenously dosed 2 minutes prior to big ET-1 challenge.

摘要

WS79089B是一种高度特异性的内皮素转化酶(ECE)抑制剂,它是从玫瑰链霉菌79089号菌株的发酵液中分离得到的。WS79089B表现出高度选择性的ECE抑制活性,IC50值为0.14微摩尔,并且作为ECE的竞争性抑制剂,Ki值为8.9×10⁻⁸ M。当在给雄性Sprague-Dawley大鼠静脉注射WS79089B的钠盐(FR901533)2分钟后再注射大内皮素-1(big ET-1)进行攻击时,它能以剂量依赖的方式抑制big ET-1诱导的升压作用。

相似文献

1
Biological and pharmacological properties of highly selective new endothelin converting enzyme inhibitor WS79089B isolated from Streptosporangium roseum No. 79089.从玫瑰链霉菌79089中分离得到的高选择性新型内皮素转化酶抑制剂WS79089B的生物学和药理学特性
J Antibiot (Tokyo). 1995 Feb;48(2):169-74. doi: 10.7164/antibiotics.48.169.
2
WS79089A, B and C, new endothelin converting enzyme inhibitors isolated from Streptosporangium roseum. No. 79089. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.WS79089A、B和C,从玫瑰链霉菌79089号菌株中分离出的新型内皮素转化酶抑制剂。分类学、发酵、分离、理化性质及生物活性
J Antibiot (Tokyo). 1994 Jun;47(6):619-30. doi: 10.7164/antibiotics.47.619.
3
Effect of a highly selective endothelin-converting enzyme inhibitor on cardiac remodeling in rats after myocardial infarction.一种高选择性内皮素转换酶抑制剂对大鼠心肌梗死后心脏重构的影响。
J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S367-70. doi: 10.1097/00005344-200036051-00106.
4
Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery.内皮素转化酶抑制剂对大内皮素-1诱导的离体大鼠基底动脉收缩的影响。
Acta Neurochir (Wien). 2002 Nov;144(11):1213-9. doi: 10.1007/s00701-002-1000-z.
5
WS75624 A and B, new endothelin converting enzyme inhibitors isolated from Saccharothrix sp. No. 75624. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.WS75624 A和B,从糖丝菌属75624号菌株中分离出的新型内皮素转化酶抑制剂。I. 分类学、发酵、分离、理化性质及生物学活性。
J Antibiot (Tokyo). 1995 Oct;48(10):1066-72. doi: 10.7164/antibiotics.48.1066.
6
Pharmacological profiles of aspergillomarasmines as endothelin converting enzyme inhibitors.
Jpn J Pharmacol. 1993 Oct;63(2):187-93. doi: 10.1254/jjp.63.187.
7
Pharmacological characterization of a novel sulfonylureid-pyrazole derivative, SM-19712, a potent nonpeptidic inhibitor of endothelin converting enzyme.新型磺酰脲-吡唑衍生物SM-19712(一种有效的内皮素转化酶非肽类抑制剂)的药理学特性
Jpn J Pharmacol. 2000 Sep;84(1):7-15. doi: 10.1254/jjp.84.7.
8
[D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.[D-缬氨酸22]大内皮素-1[16-38]抑制内皮素转化酶活性:预防脑血管痉挛的一个有前景的概念。
Neurosurg Rev. 2003 May;26(2):125-32. doi: 10.1007/s10143-002-0242-9. Epub 2002 Nov 19.
9
Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11.内皮素转化酶和中性内肽酶24.11的口服活性双重抑制剂对大内皮素-1诱导的升压反应的抑制作用
J Cardiovasc Pharmacol. 1995;26 Suppl 3:S69-71.
10
Pharmacological properties of CGS 35066, a potent and selective endothelin-converting enzyme inhibitor, in conscious rats.强效选择性内皮素转化酶抑制剂CGS 35066在清醒大鼠体内的药理特性
J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S40-3. doi: 10.1097/00005344-200036051-00015.

引用本文的文献

1
The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?内皮素系统作为心血管疾病的治疗靶点:厚望还是空想?
Br J Pharmacol. 2008 Mar;153(6):1105-19. doi: 10.1038/sj.bjp.0707516. Epub 2007 Oct 29.
2
Secretory pathways in endothelin synthesis.内皮素合成中的分泌途径。
Br J Pharmacol. 1999 Jan;126(2):391-8. doi: 10.1038/sj.bjp.0702315.